PROCTER & GAMBLE HEALTH | RPG LIFE SCIENCES | PROCTER & GAMBLE HEALTH/ RPG LIFE SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 30.6 | 113.1% | View Chart |
P/BV | x | 10.6 | 8.4 | 125.2% | View Chart |
Dividend Yield | % | 2.0 | 0.8 | 262.7% |
PROCTER & GAMBLE HEALTH RPG LIFE SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
RPG LIFE SCIENCES Mar-23 |
PROCTER & GAMBLE HEALTH/ RPG LIFE SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,012 | 530.0% | |
Low | Rs | 3,883 | 452 | 859.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 310.0 | 238.9% | |
Earnings per share (Unadj.) | Rs | 138.2 | 40.9 | 338.0% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 50.3 | 308.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 12.00 | 791.7% | |
Avg Dividend yield | % | 2.1 | 1.6 | 125.3% | |
Book value per share (Unadj.) | Rs | 447.6 | 186.0 | 240.7% | |
Shares outstanding (eoy) | m | 16.60 | 16.54 | 100.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.4 | 264.4% | |
Avg P/E ratio | x | 33.5 | 17.9 | 186.9% | |
P/CF ratio (eoy) | x | 29.8 | 14.6 | 204.6% | |
Price / Book Value ratio | x | 10.3 | 3.9 | 262.4% | |
Dividend payout | % | 68.7 | 29.3 | 234.2% | |
Avg Mkt Cap | Rs m | 76,761 | 12,109 | 633.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 1,171 | 176.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 5,128 | 239.8% | |
Other income | Rs m | 184 | 48 | 383.1% | |
Total revenues | Rs m | 12,480 | 5,176 | 241.1% | |
Gross profit | Rs m | 3,247 | 1,035 | 313.6% | |
Depreciation | Rs m | 281 | 155 | 181.4% | |
Interest | Rs m | 8 | 12 | 67.0% | |
Profit before tax | Rs m | 3,142 | 917 | 342.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 240 | 352.5% | |
Profit after tax | Rs m | 2,295 | 676 | 339.3% | |
Gross profit margin | % | 26.4 | 20.2 | 130.8% | |
Effective tax rate | % | 27.0 | 26.2 | 102.8% | |
Net profit margin | % | 18.7 | 13.2 | 141.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 2,641 | 443.6% | |
Current liabilities | Rs m | 6,791 | 1,028 | 660.7% | |
Net working cap to sales | % | 40.0 | 31.4 | 127.3% | |
Current ratio | x | 1.7 | 2.6 | 67.1% | |
Inventory Days | Days | 263 | 46 | 576.6% | |
Debtors Days | Days | 343 | 266 | 128.9% | |
Net fixed assets | Rs m | 10,617 | 1,553 | 683.6% | |
Share capital | Rs m | 166 | 132 | 125.5% | |
"Free" reserves | Rs m | 7,265 | 2,944 | 246.8% | |
Net worth | Rs m | 7,431 | 3,076 | 241.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 4,194 | 532.5% | |
Interest coverage | x | 409.1 | 80.7 | 506.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.2 | 45.0% | |
Return on assets | % | 10.3 | 16.4 | 62.9% | |
Return on equity | % | 30.9 | 22.0 | 140.4% | |
Return on capital | % | 42.4 | 30.2 | 140.5% | |
Exports to sales | % | 0 | 31.7 | 0.0% | |
Imports to sales | % | 13.1 | 3.9 | 333.9% | |
Exports (fob) | Rs m | NA | 1,624 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 201 | 800.7% | |
Fx inflow | Rs m | 1,465 | 1,624 | 90.2% | |
Fx outflow | Rs m | 1,605 | 201 | 800.7% | |
Net fx | Rs m | -140 | 1,424 | -9.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 908 | 259.9% | |
From Investments | Rs m | -215 | -1,058 | 20.3% | |
From Financial Activity | Rs m | -985 | -171 | 575.2% | |
Net Cashflow | Rs m | 1,160 | -321 | -361.4% |
Indian Promoters | % | 0.0 | 72.8 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 3.1 | 652.6% | |
FIIs | % | 6.2 | 0.9 | 693.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 27.2 | 177.2% | |
Shareholders | 56,778 | 22,137 | 256.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | RPG LIFE SCIENCES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.70% | 0.45% |
1-Month | -1.15% | 4.91% | 2.55% |
1-Year | 0.73% | 93.47% | 56.14% |
3-Year CAGR | -8.76% | 51.20% | 15.22% |
5-Year CAGR | 4.97% | 40.73% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the RPG LIFE SCIENCES share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of RPG LIFE SCIENCES the stake stands at 72.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of RPG LIFE SCIENCES.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
RPG LIFE SCIENCES paid Rs 12.0, and its dividend payout ratio stood at 29.3%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of RPG LIFE SCIENCES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.